ITL Group achieves double ISO 13485:2016 recertification

ITL Group (a G&H company) receives ISO 13485:2016 recertification for its Quality Management System throughout its UK and US operations following a review by the British Standards Institute (BSI).

Last month, BSI visited ITL headquarters in Ashford, Kent to perform a recertification audit to ISO 13485:2016. The Group was recommended for continuing certification pending the outcome of an on-site audit at ITL’s manufacturing facility in Ashland, Virginia.

ITL Virginia Inc (ITL VA), which is listed on ITL’s ISO 13485 certificate as an additional site, underwent an annual surveillance audit on the 23rd and 24th September and was successfully recommended for recertification.

BSI’s consistent approach to both UK and US audits provides reassurance to ITL as a global subcontract design and manufacturing organization for ongoing compliance.

Andrew Goodenough, Quality Assurance and Regulatory Affairs Manager commented,

“We are delighted to have our quality processes repeatedly recognised with formal certification. It demonstrates our global commitment to quality, to meeting customer needs and international regulatory requirements, as well as helping our customers enhance the safety and conformity of their medical devices.”

Managing Director, Tom Cole said,

“Achieving recertification is a great accomplishment by our respective site teams and an excellent example of ITL’s commitment to delivering the highest levels of quality and regulatory compliance to our customers.”



You may also like...

News
ITL Group | Year in Review & Year to Come

The Group celebrates another year of tremendous success in fiscal 2019. These results are underpinned by a world class customer base, strong global reach and depth of expertise.

Explore the highlights and successes from our year.

Read more >

Resource
If you already sell it in China, why not make it there too?

This article looks at the best options for manufacturing products for the Chinese home market, and in particular the market for medical devices and in-vitro diagnostic instruments. Basically, is it best to manufacture in Europe or China for the Chinese market – and why?

Read more >

Case Study
Magnasense

From lab based analysis to mobile and disposable ‘point of care testing’ (POCT)

View this case study >